These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 24338470)

  • 41. Neuropathic pain and spasticity: intricate consequences of spinal cord injury.
    Finnerup NB
    Spinal Cord; 2017 Dec; 55(12):1046-1050. PubMed ID: 28695904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropathic pain: mechanisms, therapeutic approach, and interpretation of clinical trials.
    Attal N
    Continuum (Minneap Minn); 2012 Feb; 18(1):161-75. PubMed ID: 22810075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The CanPain SCI Clinical Practice Guidelines for Rehabilitation Management of Neuropathic Pain after Spinal Cord: screening and diagnosis recommendations.
    Mehta S; Guy SD; Bryce TN; Craven BC; Finnerup NB; Hitzig SL; Orenczuk S; Siddall PJ; Widerström-Noga E; Casalino A; Côté I; Harvey D; Kras-Dupuis A; Lau B; Middleton JW; Moulin DE; O'Connell C; Parrent AG; Potter P; Short C; Teasell R; Townson A; Truchon C; Wolfe D; Bradbury CL; Loh E
    Spinal Cord; 2016 Aug; 54 Suppl 1():S7-S13. PubMed ID: 27444717
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pain assessment in hospitalized spinal cord injured patients - a controlled cross-sectional study.
    Rosendahl A; Krogh S; Kasch H
    Scand J Pain; 2019 Apr; 19(2):299-307. PubMed ID: 30422806
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contribution of mechanoreceptors to spinal cord injury-induced mechanical allodynia.
    Sliwinski C; Heutehaus L; Taberner FJ; Weiss L; Kampanis V; Tolou-Dabbaghian B; Cheng X; Motsch M; Heppenstall PA; Kuner R; Franz S; Lechner SG; Weidner N; Puttagunta R
    Pain; 2024 Jun; 165(6):1336-1347. PubMed ID: 38739766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuropathic Pain and Functional Reorganization in the Primary Sensorimotor Cortex After Spinal Cord Injury.
    Jutzeler CR; Freund P; Huber E; Curt A; Kramer JLK
    J Pain; 2015 Dec; 16(12):1256-1267. PubMed ID: 26392031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Referred sensations and neuropathic pain following spinal cord injury.
    Soler MD; Kumru H; Vidal J; Pelayo R; Tormos JM; Fregni F; Navarro X; Pascual-Leone A
    Pain; 2010 Jul; 150(1):192-198. PubMed ID: 20471171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial.
    Rabi J; Minori J; Abad H; Lee R; Gittler M
    Int J Pharm Compd; 2016; 20(6):517-520. PubMed ID: 28339391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropathic pain prevalence following spinal cord injury: A systematic review and meta-analysis.
    Burke D; Fullen BM; Stokes D; Lennon O
    Eur J Pain; 2017 Jan; 21(1):29-44. PubMed ID: 27341614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms.
    Ahn SH; Park HW; Lee BS; Moon HW; Jang SH; Sakong J; Bae JH
    Spine (Phila Pa 1976); 2003 Feb; 28(4):341-6; discussion 346-7. PubMed ID: 12590206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reaction to topical capsaicin in spinal cord injury patients with and without central pain.
    Finnerup NB; Pedersen LH; Terkelsen AJ; Johannesen IL; Jensen TS
    Exp Neurol; 2007 May; 205(1):190-200. PubMed ID: 17346705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Residual spinothalamic tract pathways predict development of central pain after spinal cord injury.
    Wasner G; Lee BB; Engel S; McLachlan E
    Brain; 2008 Sep; 131(Pt 9):2387-400. PubMed ID: 18669485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The chronic neuropathic pain of spinal cord injury: which efficiency of neuropathic stimulation?
    Lagauche D; Facione J; Albert T; Fattal C
    Ann Phys Rehabil Med; 2009 Mar; 52(2):180-7. PubMed ID: 19909708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indicators of central sensitization in chronic neuropathic pain after spinal cord injury.
    Lütolf R; Rosner J; Curt A; Hubli M
    Eur J Pain; 2022 Nov; 26(10):2162-2175. PubMed ID: 36008094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sensory function above lesion level in spinal cord injury patients with and without pain.
    Finnerup NB; Johannesen IL; Bach FW; Jensen TS
    Somatosens Mot Res; 2003; 20(1):71-6. PubMed ID: 12745445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. What are the risk factors of occurence and chronicity of neuropathic pain in spinal cord injury patients?
    Margot-Duclot A; Tournebise H; Ventura M; Fattal C
    Ann Phys Rehabil Med; 2009 Mar; 52(2):111-23. PubMed ID: 19909702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pain after spinal cord injury: a review of classification, treatment approaches, and treatment assessment.
    Cardenas DD; Felix ER
    PM R; 2009 Dec; 1(12):1077-90. PubMed ID: 19797006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reliability and validity of quantitative sensory testing in persons with spinal cord injury and neuropathic pain.
    Felix ER; Widerström-Noga EG
    J Rehabil Res Dev; 2009; 46(1):69-83. PubMed ID: 19533521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropathic Pain and Spinal Cord Injury: Phenotypes and Pharmacological Management.
    Widerström-Noga E
    Drugs; 2017 Jun; 77(9):967-984. PubMed ID: 28451808
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropathic pain following traumatic spinal cord injury: Models, measurement, and mechanisms.
    Kramer JL; Minhas NK; Jutzeler CR; Erskine EL; Liu LJ; Ramer MS
    J Neurosci Res; 2017 Jun; 95(6):1295-1306. PubMed ID: 27617844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.